Clinical Trial Update: Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update announces recruitment for a study evaluating curative therapy after initial treatment with atezolizumab and bevacizumab in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatocellular Carcinoma | Status: RECRUITING